MorphoSys AG MOR
Set alert
18.96 +18.96 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.86B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -6.36
- Beta
- 0.66
- Short ratio
- 2.65
- Inst. own
- 7.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 29, 2024
- 50-d avg
- 18.46
- 200-d avg
- 14.74
- 1y target
- 14.16
Analyst view
Consensus: hold
Hold
Price target (mean) 14.16 -25.3% downside
Now 18.96
- Target (low)
- 11.60
- Target (mean)
- 14.16
- Target (high)
- 16.71
Recommendation trend
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.21 | -1.21 – -1.21 | -0.57 | -112.3% | 65.00M | +15.7% | 1 |
| Next quarter | -1.21 | -1.21 – -1.21 | -0.95 | -27.4% | 69.00M | +0.1% | 1 |
| Current year | -5.66 | -5.66 – -5.66 | -1.50 | -277.3% | 284.55M | +10.0% | 1 |
| Next year | -2.98 | -2.98 – -2.98 | -5.66 | +47.3% | 382.00M | +34.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2023 | Morgan Stanley | Upgrade | Underweight | Overweight |
| Sep 14, 2023 | Goldman Sachs | Upgrade | Sell | Neutral |
| Jun 21, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 15, 2023 | Wells Fargo | Initiated | — | Overweight |
| Jun 15, 2023 | JP Morgan | Upgrade | Underweight | Overweight |
| Jan 2, 2023 | JP Morgan | Downgrade | Neutral | Underweight |
| Nov 17, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Jan 13, 2022 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Aug 5, 2021 | Deutsche Bank | Downgrade | Buy | Hold |
| Jun 10, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Jun 2, 2021 | Bryan Garnier | Downgrade | Buy | Neutral |
| Jun 2, 2021 | SVB Leerink | Upgrade | Market Perform | Outperform |
| May 23, 2021 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Mar 22, 2021 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Nov 24, 2020 | Morgan Stanley | Initiated | — | Equal-Weight |
| Nov 19, 2019 | Guggenheim | Initiated | — | Buy |
| Nov 13, 2018 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 4, 2018 | Piper Sandler | Initiated | — | Overweight |
| May 13, 2018 | JMP Securities | Initiated | — | Market Outperform |